AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / LABORATORY ANALYTICAL INSTRUMENTS
Bionano Genomics, Inc. Common Stock
XNAS · usd
SIC 3826 · LABORATORY ANALYTICAL INSTRUMENTS
FIGI BBG001V0SSM6
1.13▼ 0.05 (-4.24%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
1.18
Day's Range
1.10 – 1.18
52-Week Range
1.00 – 2.23
Volume
250.5K
Avg Volume
1.8M
Share Statistics
Shares Outstanding
Employees
97
Exchange
XNAS
Listed
2018-08-01
Share count as of August 6, 2026

Bionano Genomics, Inc. Common Stock (BNGO) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Bionano Genomics, Inc. Common Stock (BNGO)
What is Bionano Genomics, Inc. Common Stock's Market Cap?
Bionano Genomics, Inc. Common Stock's Market Cap is $13.3M, based on as-reported figures from SEC (XBRL) filings.
What is Bionano Genomics, Inc. Common Stock's Enterprise Value?
Bionano Genomics, Inc. Common Stock's Enterprise Value is $13.3M, based on as-reported figures from SEC (XBRL) filings.
What is Bionano Genomics, Inc. Common Stock's Price / Sales?
Bionano Genomics, Inc. Common Stock's Price / Sales is 0.4×, based on as-reported figures from SEC (XBRL) filings.
What is Bionano Genomics, Inc. Common Stock's EV / Revenue?
Bionano Genomics, Inc. Common Stock's EV / Revenue is 0.4×, based on as-reported figures from SEC (XBRL) filings.
What is Bionano Genomics, Inc. Common Stock's EV / EBITDA?
Bionano Genomics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Bionano Genomics, Inc. Common Stock's Revenue (TTM)?
Bionano Genomics, Inc. Common Stock's Revenue (TTM) is $30.2M, based on as-reported figures from SEC (XBRL) filings.
What is Bionano Genomics, Inc. Common Stock's Net Income (TTM)?
Bionano Genomics, Inc. Common Stock's Net Income (TTM) is -$32.2M, based on as-reported figures from SEC (XBRL) filings.
What is Bionano Genomics, Inc. Common Stock's EBITDA?
Bionano Genomics, Inc. Common Stock's EBITDA is -$22.9M, based on as-reported figures from SEC (XBRL) filings.
What is Bionano Genomics, Inc. Common Stock's Diluted EPS (TTM)?
Bionano Genomics, Inc. Common Stock's Diluted EPS (TTM) is -2.73, based on as-reported figures from SEC (XBRL) filings.
What is Bionano Genomics, Inc. Common Stock's EBITDA Margin?
Bionano Genomics, Inc. Common Stock's EBITDA Margin is -75.8%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · BNGOAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Total revenue
YoY growth+21.4%+3.6%-2.6%+21.3%
Cost of revenue:
Total cost of revenue
Operating expenses:
Research and development
Selling, general and administrative
Goodwill impairment————
Intangible assets and other long-lived assets impairment——
Restructuring costs——
Total operating expenses
% of revenue141.1%166.7%150.1%161.6%
Loss from operations
% of revenue-88.3%-118.1%-107.4%-115.9%
Other income (expense):
Interest income
Other income (expense)
Total other income (expense)
Loss before income taxes
Provision for income taxes
Net loss
% of revenue-90.8%-124.2%-99.8%-115.4%
Net loss per share, basic (in dollars per share)—
Net loss per share, diluted (in dollars per share)—